United Capital Financial Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-208,000
Closed -$400 1074
2024
Q3
$400 Buy
208,000
+207,600
+51,900% +$111M ﹤0.01% 1060
2024
Q2
$217K Hold
400
﹤0.01% 957
2024
Q1
$207K Buy
+400
New +$199K ﹤0.01% 1010

Other funds holding ELV

United Capital Financial Advisors's ELV Position: Q1 2026 in Review

United Capital Financial Advisors reduced its Elevance Health (ELV) stake by 7.3% in Q1 2026, selling an estimated $209K and leaving 8,128 shares worth $2.38M. The position accounts for 0.01% of the portfolio, ranked #512.

United Capital Financial Advisors first reported a position in ELV in Q2 2013 and has held it in 51 quarters since. The position peaked at $4.24M in Q1 2022. 1,467 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • United Capital Financial Advisors held 8,128 shares of Elevance Health worth $2.38M as of Q1 2026.
  • United Capital Financial Advisors sold 636 Elevance Health shares in Q1 2026, an estimated $209K.
  • Elevance Health made up 0.01% of United Capital Financial Advisors's portfolio in Q1 2026, its #512 holding.
  • United Capital Financial Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 51 quarters since.
  • United Capital Financial Advisors's Elevance Health position peaked at $4.24M in Q1 2022.
  • 1,467 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on United Capital Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.